Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Joel Palefsky
University of California San Francisco
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
149
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Comparison of AmpFire and MY09/11 Assays for HPV Genotyping in Anogenital Specimen of Rwandan Men Who Have Sex with Men
Number of pages: 20
Posted: 27 Sep 2022
Faustin Kanyabwisha
,
Hae-Young Kim
,
Qiuhu Shi
,
Gad Murenzi
,
Patrick Tuyisenge
,
Gallican Kubwimana
,
Athanase Munyaneza
,
Anthere Murangwa
,
Onesphore Turizigiye
,
Maria Da Costa
,
Boniface Nsengiyumva
,
Xin Chen
,
Leon Mutesa
,
Kathryn Anastos
and Joel Palefsky
Rwanda Military Hospital (RMH), New York Medical College, New York Medical College, Rwanda Military Hospital (RMH), Rwanda Military Hospital (RMH), Rwanda Military Hospital (RMH), Rwanda Military Hospital (RMH), Rwanda Military Hospital (RMH), Rwanda Military Hospital (RMH), University of California San Francisco, Rwanda Military Hospital (RMH), Atila Biosystems Inc, University of Rwanda, Yeshiva University - Albert Einstein College of Medicine and University of California San Francisco
Downloads
89
(747,755)
View PDF
Download
Abstract:
MSM, MY09/11, AmpFire, anal hrHPV, penile hrHPV
2.
IPVS Policy Statement on HPV Nucleic Acid Testing Guidance for Those Utilising/Considering HPV as Primary Precancer Screening: Quality Assurance and Quality Control Issues
Number of pages: 26
Posted: 03 Aug 2022
Suzanne Marie Garland
,
Thomas Iftner
,
Kate Cuschieri
,
Andreas Kaufmann
,
Marc Arbyn
,
Silvia de Sanjose
,
Mario Poljak
,
Joakim Dillner
,
Elizabeth R. Unger
,
Margaret Stanley
,
Anna-Barbara Moscicki
,
Yin Ling Woo
,
Neerja Bhatla
,
Karen L. Chan
, Joel Palefsky,
Anna Giuliano
,
Julia ML Brotherton
and
Sarah Feldman
The Royal Women’s Hospital - Centre for Women’s Infectious Diseases Research, University of Tübingen - Institute for Medical Virology and Epidemiology of Viral Diseases, Royal Infirmary of Edinburgh - Scottish HPV Reference Laboratory, Charité - Universitätsmedizin Berlin, Scientific Institute of Public Health - Unit of Cancer Epidemiology, National Institutes of Health, ISGlobal, University of Ljubljana - Institute of Microbiology and Immunology, Karolinska Institutet - Department of Laboratory Medicine, Government of the United States of America - Division of High Consequence Pathogens and Pathology, University of Cambridge - Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, University of Malaya (UM), All India Institute of Medical Sciences (AIIMS), The University of Hong Kong - Queen Mary Hospital, University of California San Francisco, University of South Florida - Morsani College of Medicine, Australian Centre for the Prevention of Cervical Cancer and Harvard University - Brigham and Women’s Hospital
Downloads
60
(961,006)
View PDF
Download
Abstract:
HPV, primary, cervical, screening, validation
Feedback